Skip to Main Content


GlucaGen HypoKit Recall

Date: 09/20/16

On September 9th, 2016 the U.S. Food and Drug Administration (FDA) released a product recall to the wholesale and retail level, including hospitals and pharmacies. The recall involves GlucaGen HypoKit (glucagon [rDNA origin] for injection) manufactured by Novo Nordisk Inc.

Novo Nordisk Inc. is recalling six batches of the GlucaGen HypoKit in the U.S. due to two customer complaints from the UK and Portugal involving detached needles on the syringe with Sterile Water for Injection (SWFI). A syringe with a detached needle cannot be used as prescribed.

Click here for important details about this recall.

Last Updated: 04/15/2020